These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
274 related items for PubMed ID: 8051416
1. Resistance of Actinobacillus pleuropneumoniae to bactericidal antibody and complement is mediated by capsular polysaccharide and blocking antibody specific for lipopolysaccharide. Ward CK, Inzana TJ. J Immunol; 1994 Sep 01; 153(5):2110-21. PubMed ID: 8051416 [Abstract] [Full Text] [Related]
2. Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition. Joiner KA, Goldman RC, Hammer CH, Leive L, Frank MM. J Immunol; 1983 Nov 01; 131(5):2563-9. PubMed ID: 6355296 [Abstract] [Full Text] [Related]
3. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage. Joiner KA, Goldman RC, Hammer CH, Leive L, Frank MM. J Immunol; 1983 Nov 01; 131(5):2570-5. PubMed ID: 6355297 [Abstract] [Full Text] [Related]
4. Complement-mediated killing of the Lyme disease spirochete Borrelia burgdorferi. Role of antibody in formation of an effective membrane attack complex. Kochi SK, Johnson RC, Dalmasso AP. J Immunol; 1991 Jun 01; 146(11):3964-70. PubMed ID: 2033266 [Abstract] [Full Text] [Related]
5. Serologic detection of Actinobacillus pleuropneumoniae in swine by capsular polysaccharide-biotin-streptavidin enzyme-linked immunosorbent assay. Inzana TJ, Fenwick B. J Clin Microbiol; 2001 Apr 01; 39(4):1279-82. PubMed ID: 11283041 [Abstract] [Full Text] [Related]
6. The interaction of Escherichia coli with normal human serum: the kinetics of serum-mediated lipopolysaccharide release and its dissociation from bacterial killing. Tesh VL, Duncan RL, Morrison DC. J Immunol; 1986 Aug 15; 137(4):1329-35. PubMed ID: 3525676 [Abstract] [Full Text] [Related]
7. Antibodies specific to surface antigens are not effective in complement-mediated killing of Haemophilus ducreyi. Frisk A, Ahmed HJ, Van Dyck E, Lagergård T. Microb Pathog; 1998 Aug 15; 25(2):67-75. PubMed ID: 9712686 [Abstract] [Full Text] [Related]
8. Human IgA1 initiates complement-mediated killing of Neisseria meningitidis. Jarvis GA, Griffiss JM. J Immunol; 1989 Sep 01; 143(5):1703-9. PubMed ID: 2474610 [Abstract] [Full Text] [Related]
10. Vibrio cholerae O139 capsular polysaccharide confers complement resistance in the absence or presence of antibody yet presents a productive target for cell lysis: implications for detection of bactericidal antibodies. Attridge SR, Holmgren J. Microb Pathog; 2009 Dec 01; 47(6):314-20. PubMed ID: 19818394 [Abstract] [Full Text] [Related]
16. Opsonization of encapsulated Staphylococcus aureus: the role of specific antibody and complement. Verbrugh HA, Peterson PK, Nguyen BY, Sisson SP, Kim Y. J Immunol; 1982 Oct 01; 129(4):1681-7. PubMed ID: 7108223 [Abstract] [Full Text] [Related]
18. Human IgA1 blockade of IgG-initiated lysis of Neisseria meningitidis is a function of antigen-binding fragment binding to the polysaccharide capsule. Jarvis GA, Griffiss JM. J Immunol; 1991 Sep 15; 147(6):1962-7. PubMed ID: 1909736 [Abstract] [Full Text] [Related]
19. Preparation, characterization, and immunogenicity of conjugate vaccines directed against Actinobacillus pleuropneumoniae virulence determinants. Byrd W, Kadis S. Infect Immun; 1992 Aug 15; 60(8):3042-51. PubMed ID: 1639471 [Abstract] [Full Text] [Related]
20. Studies on the mechanism of bacterial resistance to complement-mediated killing. III. C5b-9 deposits stably on rough and type 7 S. pneumoniae without causing bacterial killing. Joiner K, Brown E, Hammer C, Warren K, Frank M. J Immunol; 1983 Feb 15; 130(2):845-9. PubMed ID: 6848598 [Abstract] [Full Text] [Related] Page: [Next] [New Search]